New diabetes clinical trial: Precision T1D Platform
Published on: 2026-05-18T04:00:00Z Conditions : Type 1 Diabetes; T1D Diabetic Chronic Kidney Disease; T1D Heart Failure; Cardio-renal Vascular Function and Failure Interventions : Drug: Finerenone; Drug: Sotagliflozin Sponsors : Oregon Health and Science University; University of Michigan; Breakthrough T1D Not yet recruiting https://ift.tt/VylCTaw